Clinical trial
Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass.
NCT00190034 · Far Eastern Memorial Hospital, Other · Suspended
Key facts
| NCT number | NCT00190034 |
|---|---|
| Title | Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass. |
| Official title | N-Acetylcysteine Protects Against Acute Renal Insult in Patients With Abnormal Renal Function Undergoing Cardiopulmonary Bypass. |
| Lead sponsor | Far Eastern Memorial Hospital, Other |
| Collaborators | Synmosa Biopharma Corp. Industry |
| Status | Suspended |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease, Renal Insufficiency, Acute, Cardiopulmonary Bypass |
| Intervention type | Drug |
| Interventions | N-Acetylcysteine 600mg/tab |
| Enrollment | 60 |
| Start date | Jan 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 9, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: